NCLT reserves order for Dabur India's proposed Sesa Care amalgamation

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

NCLT New Delhi Bench reserved order for Dabur India-Sesa Care amalgamation on August 24, 2026. Statutory authorities recorded no-objection to the sanctioning of the scheme. Scheme falls under Sections 230 to 232 of the Companies Act, 2013. Company to notify exchanges upon receipt of final NCLT order.

powered bylight_fuzz_icon
49136015

*this image is generated using AI for illustrative purposes only.

The National Company Law Tribunal (NCLT), New Delhi Bench, has reserved its order regarding the proposed scheme of amalgamation between Dabur India and Sesa Care Private Limited. The tribunal will formally pronounce the order following the second motion petition hearing held on August 24, 2026.

This development follows a series of regulatory approvals and intimations issued by the company since May 2025. The statutory authorities have recorded their no-objection to the sanctioning of the scheme under Sections 230 to 232 of the Companies Act, 2013.

Regulatory Progress

The amalgamation involves Sesa Care Private Limited as the transferor company and Dabur India Limited as the transferee company. The process includes the consolidation of shareholders and creditors from both entities.

Dabur India has notified the stock exchanges of the reserved order status. The company stated it will issue further notifications and update its website upon receipt of the final copy of the NCLT order. This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Dabur India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.51%-1.68%-6.49%-22.53%-22.74%-34.67%

How is the final NCLT order expected to impact Dabur India's short-term stock price volatility and long-term valuation metrics?

What specific operational synergies or cost-saving measures does Dabur anticipate realizing from integrating Sesa Care's assets and workforce?

Will the amalgamation alter Dabur's strategic focus on its healthcare segment, potentially shifting resource allocation away from core FMCG products?

Dabur India approves ₹5.50 final dividend, reappoints directors at AGM

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Dabur India Limited shareholders approved a ₹5.50 final dividend for FY26 and reappointed directors Saket Burman, Rajiv Mehrishi, and Mukesh Hari Butani at its 51st AGM. All seven resolutions, including financial statement adoption and cost auditor ratification, passed with significant majority support.

powered bylight_fuzz_icon
47647660

*this image is generated using AI for illustrative purposes only.

Shareholders of Dabur India Limited have approved a final dividend of ₹5.50 per equity share of Re. 1/- each for the financial year ended March 31, 2026, confirming a total payout ratio of 825% when combined with the interim dividend. The approval came during the company’s 51st Annual General Meeting (AGM), held on August 6, 2026, via Video Conferencing/Other Audio Visual Means (VC/OAVM). This declaration signals continued confidence in cash generation capabilities, with the final dividend payable on or before September 4, 2026.

The AGM transacted seven items of business as per the notice dated May 7, 2026. Shareholders overwhelmingly supported the adoption of both standalone and consolidated audited financial statements for FY26. The voting process was scrutinized by CS Navneet Arora of M/s Navneet K Arora & Co LLP, appointed by the Board on May 7, 2026, pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014. KFin Technologies Ltd served as the authorized agency for e-voting.

Key Resolutions Passed

The following table summarizes the voting outcomes for the major resolutions considered at the AGM:

Resolution Description Type Votes In Favor (%) Votes Against (%) Status
Adoption of Standalone Financial Statements Ordinary 99.9998 0.0002 Passed
Adoption of Consolidated Financial Statements Ordinary 99.9998 0.0002 Passed
Final Dividend of ₹5.50 per share Ordinary 99.9997 0.0003 Passed
Re-appointment of Saket Burman Ordinary 98.8646 1.1354 Passed
Re-appointment of Rajiv Mehrishi (Independent Director) Special 99.1268 0.8732 Passed
Modification of term for Mukesh Hari Butani (Independent Director) Special 97.0141 2.9859 Passed
Ratification of Cost Auditor Remuneration Ordinary 99.9997 0.0003 Passed

Director Appointments and Governance

The shareholders approved the re-appointment of Mr. Saket Burman (DIN: 05208674), who retired by rotation, with 98.86% support. Notably, while promoter and promoter group shareholders voted unanimously in favor, public institutional investors showed some dissent, voting against the resolution at a rate of 4.24%.

Two special resolutions were also passed regarding independent directors. Mr. Rajiv Mehrishi (DIN: 00208189) was re-appointed for a second term of five consecutive years, effective September 1, 2026, to August 31, 2031, securing 99.13% support. Additionally, shareholders approved a modification in the term of re-appointment for Mr. Mukesh Hari Butani (DIN: 01452839) as a Non-Executive Independent Director, which received 97.01% support. Public institutional investors voted against this resolution at a higher rate of 11.15%, though it still passed comfortably.

Voting Participation and Scrutiny

The record date for determining eligibility to vote was July 30, 2026, with 492,488 shareholders on record. Participation was robust, with 197 shareholders attending via VC/OAVM (30 promoters and 167 public). E-voting constituted the vast majority of votes polled, accounting for over 99.9% of the total votes cast across all resolutions. The scrutinizer’s report confirmed that the e-voting process was conducted fairly and transparently, with no invalid votes recorded for any category in the final tally. The cost auditor’s remuneration for M/s Ramanath Iyer & Co. was also ratified by shareholders.

Historical Stock Returns for Dabur India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.51%-1.68%-6.49%-22.53%-22.74%-34.67%

How will the exceptionally high 825% payout ratio impact Dabur's internal capital allocation for R&D and expansion in FY27?

What strategic changes might Dabur implement to address the dissent from public institutional investors regarding director re-appointments?

Will the re-appointment of key independent directors signal a shift in corporate governance priorities or risk management strategies for the company?

More News on Dabur India

1 Year Returns:-22.74%